secwatch.observer — SEC 8-K summary
======================================

Issuer:     THC Farmaceuticals, Inc. (—)
CIK:        0001508594
Form:       8-K
Filed at:   2026-01-30T23:59:59+00:00
Accession:  0001096906-26-000171
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

THC Farmaceuticals changes fiscal year end to December 31, effective Dec 31, 2024
--------------------------------------------------------------------------------

- Board approved fiscal year change from September 30 to December 31 on Dec 31, 2024.
- Change aligns reporting cycle with calendar year; no articles or bylaws amendment required.
- Company will file a transition report for the short period created by the change.
- Filing of this 8-K occurred on January 26, 2026, reflecting the change.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1508594/000109690626000171/0001096906-26-000171-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1508594/000109690626000171/cbdg-20260126_8k.htm
  HTML page:      https://secwatch.observer/filing/0001096906-26-000171

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer